Variables | n = 18 (%) | |
Gender | Male Female | 14 (77.7%) 4 (22.3%) |
Etiology | HCV HBV HBV + HDV NBNC | 15 (83.3%) 1 (5.5%) 1 (5.5%) 1 (5.5%) |
Co-morbid | DM HTN IHD Hereditary spherocytosis | 4 (22.3%) 5 (27.7%) 1 (5.5%) 1 (5.5%) |
Child Class | A B | 9 (50%) 9 (50%) |
Esophageal varices | Absent Small Large | 5 (27.7%) 3 (16.6%) 10 (55.5%) |
Indication | Upper GI Bleed HCV treatment | 10 (55.5%) 8 (44.5%) |
Nature of procedure | Urgent Elective | 1 (5.5%) 17 (94.5%) |
PVA particles (micron) | 255 - 300 355 - 500 500 - 710 Both 355 - 500 & 500 - 710 | 1 (5.5%) 6 (33.3%) 11 (61.1%) 1 (5.5%) |
Percentage embolization volume | (mean ± SD) | 37.22 ± 7.321 |
Length of stay in days | (Median + Range) | 02 (01 - 25) |
Follow up in days | (Median + Range) | 304 (07 - 1126) |